期刊文献+

晚期糖基化终末产物与骨代谢紊乱 被引量:2

Advanced glycafion end-products and bone metabolic disturbance
原文传递
导出
摘要 晚期糖基化终末产物(AGEs)是碳水化合物以及Maillard反应中形成的代谢中间物,经蛋白质化学修饰后的产物。这些独特化合物是由AGEs受体识别。近来有研究指出骨蛋白也受糖基化修饰的影响。AGEs-AGE受体相互作用通过破骨细胞和成骨细胞核因子-κB途径导致细胞因子、生长因子和黏附分子的表达增加,进而导致骨重建过程紊乱,对骨质疏松发展起重要作用。另外,AGEs参与的骨组织微血管病变可能也是骨质疏松的一个病因。 Advanced glycation end-products (AGEs) are chemical modifications of proteins by carbohydrates including those metabolic intermediates formed during the Maillard reaction. These unique compounds are specifically recognized by AGE receptors. Recent findings provide importance evidence that bone proteins are also affected by AGE modification. AGEs-AGE receptors interaction results in increased expression of cytokines, growth factors and adhesion molecules via osteoclasts and osteoblasts activation of nuclear factor-κB. This interaction could especially contribute to disturbed bone remodeling and be of significant pathophysiologic importance for the development of osteoporosis. AGEs related microangiopathy at the bone tissue is also discussed as a possible reason for osteoporosis. However, the underlying molecular mechanism about osteoporosis remains to be elucidated.
出处 《国际内分泌代谢杂志》 2007年第B04期65-67,共3页 International Journal of Endocrinology and Metabolism
关键词 晚期糖基化终末产物 骨重建 成骨细胞 破骨细胞 Advanced glycation end-products Bone remodeling Osteoblast Osteoclast
  • 相关文献

参考文献16

  • 1Lu C, Hc JC, Cai W, ct al. Advanced glycation end product (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. Proc Natl Acad Sci USA, 2004,101 : 11767-11772.
  • 2Dumitriu IE, Baruah P, Valentinis B, et al. Release of high mobihty group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol, 2005,174: 7506-7515.
  • 3Wang X, Shen X, Li X, et al. Age-related changes in the collagen network and toughness of bone. Bone, 2002,31 : 1-7.
  • 4Gu L, Hagiwara S, Fan Q, et al. Role of receptor for advanced glycation end-products and signaling events in advanced glycation end-product induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes. Nephrol Dial Transplant,2006,21:299-313.
  • 5Charoonpatrapong K, Shah R, Robling AG, et al. HMGB1 expression and release by bone cells. J Cell Physiol, 2006,207:480-490.
  • 6Hermani A,De Servi B,Medunjanin S,et al. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res, 2006,312:184-197.
  • 7Inzerillo AM, Epstein S. Osteoporosis and diabetes melhtus. Rev Endocr Metab Disord, 2004,5: 261-268.
  • 8Cortizo AM, Lettieri MG, Barrio DA, et al. Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK). Mol Cell Biochem,2003,250:1-10.
  • 9Hein G, Weiss C, Lehmann G, et al. Advanced glycation end product modification of bone proteins and bone remodeling: hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis, 2006, 65 : 101-104.
  • 10Hein G, Wiegand R, Lehmann G, et al. Advanced glycation end-products pentosidine and N-carboxymethyllysine are elevated in serum of patients with osteoporosis. Rheumatology, 2003,42:1242-1246.

同被引文献33

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部